Accueil Ernstrade Bourse Actualite Stock



MorphoSys AG (MorphoSys) is a Germany-based biotechnology company focused on fully human antibodies. The Company is focused on developing and commercially exploiting technologies across a range of scientifi c spectrum. The Company operates in two segments: Therapeutic Antibodies and Antibodies Direct (AbD). Therapeutic Antibodies segment develops drug candidates on behalf of commercial partners, as well as for MorphoSys’s own product pipeline. Research Antibodies segment, delivers antibodies to the research and diagnostics markets under the brand name AbD Serotec. MorphoSys possesses the technologies in the generation of human antibody therapeutics and bespoke antibody research projects. The AbD segment leverages MorphoSys’s core technological capabilities in the design and manufacture of antibodies for research purposes. It commercializes the HuCAL technology, focusing on the custom generation of research antibodies for partners on an individual basis.


Copyright  2010